John L. Armstrong's most recent trade in CorMedix Inc was a trade of 140,000 Stock Option (Right to Buy Common Stock) done . Disclosure was reported to the exchange on Jan. 11, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CorMedix Inc | John L. Armstrong | Exec VP of Tech Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy Common Stock) | |
CorMedix Inc | John L. Armstrong | Exec VP of Tech Operations | Purchase of securities on an exchange or from another person at price $ 4.35 per share. | 14 Aug 2020 | 10,000 | 96,878 (0%) | 0% | 4.3 | 43,460 | Common Stock |
CorMedix Inc | John L. Armstrong | Exec VP of Tech Operations | Purchase of securities on an exchange or from another person at price $ 4.16 per share. | 14 Aug 2020 | 10,000 | 79,378 (0%) | 0% | 4.2 | 41,600 | Common Stock |
CorMedix Inc | John L. Armstrong | Exec VP of Tech Operations | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 14 Aug 2020 | 7,500 | 86,878 (0%) | 0% | 4.1 | 31,050 | Common Stock |